← Open Payments lookup

DAVID QURAISHI: Open Payments

NPI 1982124574 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,987 in 101 payments from 24 companies in 2025. Trend: 2023 $1,730 · 2024 $2,400 · 2025 $1,987

Food & beverage: $1,987
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$332
ABBVIE INC.15$253
Novo Nordisk Inc16$238
GlaxoSmithKline, LLC.10$186
PFIZER INC.7$141
Amgen Inc.6$100
Sumitomo Pharma America, Inc.4$100
Aimmune Therapeutics, Inc.4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$61
Astellas Pharma US Inc3$59

Products named: AIRSUPRA, TRELEGY ELLIPTA, LINZESS, Ozempic, ELIQUIS, OTEZLA, GEMTESA, ZENPEP.

Industry payments across AZ — which companies pay providers there.